Prices are updated after-hours

RFL Nyse

Rafael Holdings, Inc.

RFL 4 | $1.71 0.0% 4.2K

(0.0% 1d) (0.0% 1m) (-17.4% 1y) (0.0% 2d) (0.0% 3d) (-2.8% 7d) (-50.3% volume)
Earnings Calendar:
Market Cap: $ 40,693,342
http://www.rafaelholdings.com
Sec Filling | Patents | 19 employees

Rafael Holdings, Inc. owns interest in commercial real estate assets and clinical stage pharmaceutical companies. It operates through the Real Estate and Pharmaceuticals segments. The Real Estate segment refers to the real estate holdings. The Pharmaceuticals segment is comprised of debt interests and warrants in Rafael Pharmaceuticals and a majority equity interest in LipoMedix Pharmaceuticals. The company is headquartered in Newark, NJ.

add to watch list Paper trade email alert is off

Press-releases

Cyclo Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
Published: 2024-03-18 (Crawled : 15:30) - biospace.com/
CYTH | $1.21 7.94% 21K

Professional, Scientific, and T...

| -21.21% | O: -6.06% H: 10.32% C: 3.23%
RFL 4 | $1.71 0.0% 4.2K

Finance

| -1.16% | O: -1.16% H: 3.51% C: -0.58%
business year update therapeutics financial results

Rafael Holdings Reports Second Quarter Fiscal 2024 Financial Results
Published: 2024-03-13 (Crawled : 21:00) - globenewswire.com
CYTH | $1.21 7.94% 21K

Professional, Scientific, and T...

| -19.75% | O: -3.09% H: 8.92% C: -1.27%
RFL 4 | $1.71 0.0% 4.2K

Finance

| 2.4% | O: -1.2% H: 6.06% C: 4.24%
financial results

Cyclo Therapeutics Reports Third Quarter 2023 Financial Results
Published: 2023-11-15 (Crawled : 15:30) - biospace.com/
CYTH | $1.21 7.94% 21K

Professional, Scientific, and T...

| -11.56% | O: -10.88% H: 13.74% C: 10.69%
RFL 4 | $1.71 0.0% 4.2K

Finance

| -5.52% | O: 3.87% H: 0.0% C: -4.79%
AMTI 4 | $0.263 -14.3% -1.14% 0

Health Technology

| 57.3% | O: -10.29% H: 16.6% C: 9.53%
therapeutics financial results

Cyclo Therapeutics Announces Early Exercise of Warrants by Board Members, Management and a Significant Shareholder Resulting in Cash Proceeds of $2.4 Million
Published: 2023-10-23 (Crawled : 13:30) - biospace.com/
CYTH | $1.21 7.94% 21K

Professional, Scientific, and T...

| 38.15% | O: 6.27% H: 2.0% C: 1.0%
RFL 4 | $1.71 0.0% 4.2K

Finance

| 1.18% | O: -2.37% H: 3.64% C: -10.91%
management therapeutics

IDT Corporation Reports Fourth Quarter and Fiscal Year 2023 Results
Published: 2023-10-12 (Crawled : 20:00) - globenewswire.com
RFL 4 | $1.71 0.0% 4.2K

Finance

| -10.0% | O: 1.05% H: 0.0% C: -3.12%
IDT | $36.59 -1.03% 0.0% 41K

Communications

| 36.68% | O: 0.0% H: 9.89% C: 6.84%
year corporation results

Cyclo Therapeutics Reports Second Quarter 2023 Financial Results
Published: 2023-08-15 (Crawled : 14:00) - biospace.com/
CYTH | $1.21 7.94% 21K

Professional, Scientific, and T...

| -10.96% | O: -4.1% H: 1.41% C: -4.29%
RFL 4 | $1.71 0.0% 4.2K

Finance

| -25.97% | O: 0.0% H: 0.0% C: -3.9%
therapeutics financial results

Cyclo Therapeutics Announces Closing of $5.0 Million Private Placement with Rafael Holdings, Inc.
Published: 2023-08-02 (Crawled : 13:00) - biospace.com/
CYTH | $1.21 7.94% 21K

Professional, Scientific, and T...

| -10.34% | O: -2.76% H: 5.67% C: 5.67%
RFL 4 | $1.71 0.0% 4.2K

Finance

| -15.76% | O: 0.0% H: 2.96% C: 2.96%
therapeutics

Rafael Holdings Reports Third Quarter Fiscal 2023 Financial Results and Provides Business Update
Published: 2023-06-13 (Crawled : 20:00) - globenewswire.com
CYTH | $1.21 7.94% 21K

Professional, Scientific, and T...

| -43.48% | O: -3.48% H: 9.0% C: -5.41%
RFL 4 | $1.71 0.0% 4.2K

Finance

| -22.27% | O: 1.82% H: 0.0% C: -4.02%
business update financial results

Cyclo Therapeutics Announces Execution of Definitive Agreement with Rafael Holdings, Inc. Providing for $5.0 Million of Additional Funding Via a Private Placement
Published: 2023-06-05 (Crawled : 13:20) - biospace.com/
CYTH | $1.21 7.94% 21K

Professional, Scientific, and T...

| -7.14% | O: 4.29% H: 14.38% C: 8.9%
RFL 4 | $1.71 0.0% 4.2K

Finance

| -24.67% | O: 0.0% H: 1.76% C: 1.32%
therapeutics funding agreement

Cyclo Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results
Published: 2023-05-15 (Crawled : 13:00) - biospace.com/
CYTH | $1.21 7.94% 21K

Professional, Scientific, and T...

| 7.44% | O: 2.48% H: 0.0% C: -14.51%
RFL 4 | $1.71 0.0% 4.2K

Finance

| -10.47% | O: 0.73% H: 0.0% C: -2.29%
business update therapeutics financial results

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0000950170-24-042512	4	2024-04-08	2024-04-04	Buy	J	348259	563538
0000950170-24-042512	4	2024-04-08	2024-04-04	Sell	J	348259	0
0000950170-24-035671	4	2024-03-25	2024-03-21	Buy	F	15473	534044
0000950170-24-035670	4	2024-03-25	2024-03-21	Sell	F	2300	157362
0000950170-24-005202	4	2024-01-18	2024-01-16	Buy	A	250000	250000